OnKure Therapeutics, Inc. Variable Lease, Cost
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- OnKure Therapeutics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $42.00K, a 44.83% increase year-over-year.
- OnKure Therapeutics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $43.00K, a 4.44% decline year-over-year.
- OnKure Therapeutics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $44.00K, a 6.38% decline year-over-year.
- OnKure Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $44.00K, a 6.38% decline year-over-year.
- OnKure Therapeutics, Inc. variable lease, cost for fiscal 2025 was $162.00K, a 13.37% decline from fiscal 2024.
- OnKure Therapeutics, Inc. variable lease, cost for fiscal 2024 was $187.00K, a 6.97% decline from fiscal 2023.
- OnKure Therapeutics, Inc. variable lease, cost for fiscal 2023 was $201.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.00K 10-Q · filed 2026-08-04 | $85.00K 10-Q · filed 2026-08-04 | $129.00K derived: sum of 3 quarters · filed 2026-08-04 | $173.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $43.00K 10-Q · filed 2026-05-05 | $87.00K derived: sum of 2 quarters · filed 2026-05-05 | $131.00K derived: sum of 3 quarters · filed 2026-05-05 | $160.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $88.00K derived: sum of 2 quarters · filed 2026-03-12 | $117.00K derived: sum of 3 quarters · filed 2026-08-04 | $162.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-06 | $73.00K derived: sum of 2 quarters · filed 2026-08-04 | $118.00K 10-Q · filed 2025-11-06 | $165.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $29.00K 10-Q · filed 2026-08-04 | $74.00K 10-Q · filed 2026-08-04 | $121.00K derived: sum of 3 quarters · filed 2026-08-04 | $168.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $45.00K 10-Q · filed 2026-05-05 | $92.00K derived: sum of 2 quarters · filed 2026-05-05 | $139.00K derived: sum of 3 quarters · filed 2026-05-05 | $186.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $94.00K derived: sum of 2 quarters · filed 2026-03-12 | $141.00K derived: sum of 3 quarters · filed 2026-03-12 | $187.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $47.00K 10-Q · filed 2025-11-06 | $94.00K derived: sum of 2 quarters · filed 2025-11-06 | $140.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $47.00K 10-Q · filed 2025-08-12 | $94.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $47.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $201.00K 10-K · filed 2025-03-10 |